CAS: 1357072-61-7
| Marchio | Dati del prodotto | Purezza | Fascia di prezzo | Consegna prevista |
|---|---|---|---|---|
 | c-Met inhibitor 1 REF: AN-AG009CAKCAS: 1357072-61-7 | 98+% | 152,00 €~618,00 € | Gio 02 Mag 24 |
 | c-Met inhibitor 1 REF: TM-T10655CAS: 1357072-61-7 | 99.56% | 83,00 €~820,00 € | Gio 02 Mag 24 |
 | 6-(1-Methyl-1H-pyrazol-4-yl)-3-((2-methyl-2H-indazol-5-yl)thio)-[1,2,4]triazolo[4,3-B]pyridazine REF: 3D-HEC07261CAS: 1357072-61-7 | Min. 95% | Prezzo su richiesta | Gio 13 Giu 24 |
Ref: AN-AG009CAK
| 1mg | 177,00 € | |
| 5mg | 287,00 € | |
| 10mg | 511,00 € | |
| 25mg | 152,00 € | |
| 50mg | 173,00 € | |
| 100mg | 274,00 € | |
| 250mg | 618,00 € |
Consegna stimata in Stati Uniti, il Giovedì 02 Maggio 2024
c-Met inhibitor 1
CAS:1357072-61-7
c-Met inhibitor 1 is a c-Met receptor signaling pathway inhibitor, used for the treatment of …
Formula:
C17H14N8S
Purezza:
99.56%
Colore e forma:
Solid
Peso molecolare:
362.41
Ref: TM-T10655
| 1mg | 83,00 € | |
| 5mg | 170,00 € | |
| 10mg | 233,00 € | |
| 25mg | 388,00 € | |
| 50mg | 577,00 € | |
| 100mg | 820,00 € | |
| 1ml*10 (DMSO) | 185,00 € |
Consegna stimata in Stati Uniti, il Giovedì 02 Maggio 2024
![6-(1-Methyl-1H-pyrazol-4-yl)-3-((2-methyl-2H-indazol-5-yl)thio)-[1,2,4]triazolo[4,3-B]pyridazine](https://static.cymitquimica.com/products/3D/thumb/HEC07261.jpg)
6-(1-Methyl-1H-pyrazol-4-yl)-3-((2-methyl-2H-indazol-5-yl)thio)-[1,2,4]triazolo[4,3-B]pyridazine
CAS:1357072-61-7
6-(1-Methyl-1H-pyrazol-4-yl)-3-((2-methyl-2H-indazol-5-yl)thio)-[1,2,4]triazolo[4,3-B]pyridazine is a cMET inhibitor that blocks the activation of cMET. It has been shown …
Formula:
C17H14N8S
Purezza:
Min. 95%
Peso molecolare:
362.42 g/mol
Ref: 3D-HEC07261
| 1mg | Prezzo su richiesta | |
| 5mg | Prezzo su richiesta | |
| 10mg | Prezzo su richiesta | |
| 25mg | Prezzo su richiesta | |
| 50mg | Prezzo su richiesta |
Consegna stimata in Stati Uniti, il Giovedì 13 Giugno 2024
